Last month’s performance of -1.32% for Privia Health Group Inc (PRVA) is certainly impressive

Privia Health Group Inc (NASDAQ: PRVA) on Tuesday, soared 1.35% from the previous trading day, before settling in for the closing price of $17.73. Within the past 52 weeks, PRVA’s price has moved between $15.92 and $24.35.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

A company in the Healthcare sector has jumped its sales by 20.87% annually for the last half of the decade. The company achieved an average annual earnings per share of -20.25%. With a float of $105.88 million, this company’s outstanding shares have now reached $118.22 million.

In an organization with 1102 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 9.37%, operating margin of 0.76%, and the pretax margin is 1.45%.

Privia Health Group Inc (PRVA) Insider and Institutional Ownership

Observing investor behavior towards Health Information Services industry stocks is more important than anything else. The insider ownership of Privia Health Group Inc is 11.44%, while institutional ownership is 94.86%. The most recent insider transaction that took place on Sep 10 ’24, was worth 2,500,127. In this transaction Chief Executive Officer of this company sold 135,142 shares at a rate of $18.50, taking the stock ownership to the 247,771 shares. Before that another transaction happened on Sep 10 ’24, when Company’s Officer proposed sale 135,142 for $18.50, making the entire transaction worth $2,500,719.

Privia Health Group Inc (PRVA) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around -20.25% per share during the next fiscal year.

Privia Health Group Inc (NASDAQ: PRVA) Trading Performance Indicators

Privia Health Group Inc (PRVA) is currently performing well based on its current performance indicators. A quick ratio of 1.81 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.27. Likewise, its price to free cash flow for the trailing twelve months is 25.94.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.12, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.25 in one year’s time.

Technical Analysis of Privia Health Group Inc (PRVA)

Let’s dig in a bit further. During the last 5-days, its volume was 0.6 million. That was inferior than the volume of 0.85 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 29.18%. Additionally, its Average True Range was 0.59.

During the past 100 days, Privia Health Group Inc’s (PRVA) raw stochastic average was set at 28.75%, which indicates a significant decrease from 65.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 24.70% in the past 14 days, which was lower than the 35.00% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $18.49, while its 200-day Moving Average is $18.97. However, in the short run, Privia Health Group Inc’s stock first resistance to watch stands at $18.18. Second resistance stands at $18.39. The third major resistance level sits at $18.75. If the price goes on to break the first support level at $17.60, it is likely to go to the next support level at $17.24. The third support level lies at $17.03 if the price breaches the second support level.

Privia Health Group Inc (NASDAQ: PRVA) Key Stats

Market capitalization of the company is 2.15 billion based on 119,565K outstanding shares. Right now, sales total 1,658 M and income totals 23,080 K. The company made 422,330 K in profit during its latest quarter, and 3,470 K in sales during its previous quarter.